Early and often: reimagining patient community engagement to improve clinical trials feasibility
Parexel is proud to have collaborated with Global Genes on the whitepaper “Early and Often: Reimagining Patient Community Engagement to Improve Clinical Trials Feasibility”. In this report, you'll discover compelling findings that emphasize the critical importance of engaging patient advocacy organizations early and often to accelerate trial success while reducing costs and eliminating barriers.
This comprehensive white paper underscores how involving patient communities from the outset of clinical trial design can fundamentally transform trial outcomes. In this report, you'll discover compelling findings that emphasize the critical importance of engaging patient advocacy organizations early and often.
By adopting a patient-centric strategy, companies can accelerate trial success while reducing costs and eliminating barriers. This is more than a report—it’s a call to action for the biopharmaceutical industry to rethink its approach to rare disease clinical trials.
Related Insights
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Blog
Celebrating 40 Years of Rare Disease Progress: WODC Highlights
Jun 6, 2023
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Blog
Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients
May 3, 2022
Whitepaper
Optimizing Biosensor-based Trials
Feb 1, 2023
Blog
Including patients in DCT design
Sep 13, 2022
Blog
Rachel Smith joins Parexel as Executive Director and Head of the Rare Disease, Center of Excellence
Aug 10, 2022
Blog
Taking a Proactive Approach to Post-Launch Patient Accessibility in Strategic Planning
Aug 4, 2022
Video
A Life in a Day
Jul 28, 2022
Webinar
China's Market Approval Policy and Medical Insurance Payment System for Rare Disease
Jul 21, 2022
Related Insights
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Blog
Celebrating 40 Years of Rare Disease Progress: WODC Highlights
Jun 6, 2023
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Blog
Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients
May 3, 2022
Whitepaper
Optimizing Biosensor-based Trials
Feb 1, 2023
Blog
Including patients in DCT design
Sep 13, 2022
Blog
Rachel Smith joins Parexel as Executive Director and Head of the Rare Disease, Center of Excellence
Aug 10, 2022
Blog
Taking a Proactive Approach to Post-Launch Patient Accessibility in Strategic Planning
Aug 4, 2022
Video
A Life in a Day
Jul 28, 2022
Webinar
China's Market Approval Policy and Medical Insurance Payment System for Rare Disease
Jul 21, 2022